# Petros Christopoulos

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/petros-christopoulos/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,581 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 42 |
| i10-index | 114 |
| Last Known Institution | Heidelberg University |
| OpenAlex ID | https://openalex.org/A5018231423 |
| ORCID iD | 0000-0002-7966-8980 |
| Works | 475 |

## Researcher papers

- [Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians](https://scholariq.org/papers/implementing-tumor-mutational-burden-tmb-analysis-in-routine-diagnostics-a/)
- [Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC](https://scholariq.org/papers/comutations-and-krasg12c-inhibitor-efficacy-in-advanced-nsclc/)
- [Optimizing panel-based tumor mutational burden (TMB) measurement](https://scholariq.org/papers/optimizing-panel-based-tumor-mutational-burden-tmb-measurement/)
- [Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysis](https://scholariq.org/papers/size-matters-dissecting-key-parameters-for-panel-based-tumor-mutational-burden/)
- [Interferon-stimulated neutrophils as a predictor of immunotherapy response](https://scholariq.org/papers/interferon-stimulated-neutrophils-as-a-predictor-of-immunotherapy-response/)
- [AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients](https://scholariq.org/papers/aurka-dlgap5-tpx2-kif11-and-ckap5-five-specific-mitosis-associated-genes/)
- [Variant classification in precision oncology](https://scholariq.org/papers/variant-classification-in-precision-oncology/)
- [<i>EML4‐ALK</i> fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK<sup>+</sup> non‐small cell lung cancer](https://scholariq.org/papers/i-eml4-alk-i-fusion-variant-v3-is-a-high-risk-feature-conferring-accelerated/)
- [Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer](https://scholariq.org/papers/deep-learning-for-the-classification-of-small-cell-and-non-small-cell-lung/)
- [Tumour mutational burden: clinical utility, challenges and emerging improvements](https://scholariq.org/papers/tumour-mutational-burden-clinical-utility-challenges-and-emerging-improvements/)
- [1336P Small cell transformation in EGFR-mutated non-small cell lung cancer (EGFR+ NSCLC): Efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with platinum-based chemotherapy](https://scholariq.org/papers/1336p-small-cell-transformation-in-egfr-mutated-non-small-cell-lung-cancer-egfr/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Researcher university

- [Heidelberg University](https://scholariq.org/institutions/heidelberg-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.